sublingual delivery glp-1 receptor agonists Frontiers Glucagon-like peptide-1 receptor: mechanisms and

BMC Complement

Funding Open access funding provided by Universit degli Studi di Roma La Sapienza within the CRUI-CARE Agreement

The right source: why FDA approval and supply chains matter The FDA requires companies to spend decades studying medications to ensure that they are safe and that they work

It is not approved for pediatric use, and antidepressant treatment in younger people needs careful clinical monitoring because of boxed-warning concerns

Furthermore, much of the current knowledge is based on preclinical studies, making it difficult to extrapolate these findings to humans due to inherent differences in disease manifestation, progression, and individual biological responses